Market Research Logo

Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020

41 Pages GlobalData January 31, 2012 SKU: GBDT6827580

Canagliflozin (Type 2 Diabetes) - Analysis and Forecasts to 2020

Summary

GlobalData’s pharmaceuticals report, “Canagliflozin (Type 2 Diabetes) - Analysis and Forecasts to 2020” provides Canagliflozin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope
  • Therapy area profile including patient population for the US, EU% and Japan (seven major markets)
  • Analysis and review of Canagliflozin
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Canagliflozin including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2013-2020 for Canagliflozin in the US, EU5 and Japan
Reasons to buy
  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Show Full Description


Show Table of Contents



Canagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020

GlobalData
January 31, 2012

Search inside this report



Pricing & Delivery

Online Download
$2,000
Global Site License
$6,000

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report